An anesthesiologist’s view of problems in HIV-positive patients

  • E. V. Grigimalsky Maternity Hospital “Leleka”, Kyiv
  • A. I. Garga Maternity Hospital “Leleka”, Kyiv
  • A. V. Tarasov Maternity Hospital “Leleka”, Kyiv
  • I. N. Dovgiy Maternity Hospital “Leleka”, Kyiv
  • N. N. Budnyk Maternity Hospital “Leleka”, Kyiv
Keywords: HIV infection, perioperative period, treatment, patient, caesarean section


Currently, HIV infection is becoming epidemic. More than 42% of HIV-infected people in the world are women of childbearing age. With the onset of antiretroviral therapy, chemoprophylaxis during pregnancy, and planned cesarean section, the risk of perinatal HIV transmission decreases to 1–2%. However, various side effects such as anemia, neutropenia, thrombocytopenia, fatty liver dystrophy, toxic hepatitis, acute pancreatitis, increased serum transaminases, changes in biochemical parameters of liver function, impaired glucose tolerance, and hypocoagulation may occur in the context of antiretroviral therapy. This poses to the anesthesiologist a number of new tasks to ensure patient safety during the perioperative period.


Download data is not yet available.


Lorenzi P., Spicher V.M., Laubereau B., et al. Antiretroviral therapies in pregnancy: maternal, fetal and neonatal effects // Swiss HIV Cohort Study, the Swiss Collaborative HIV and Pregnancy Study, and the Swiss Neonatal HIV Study. AIDS, 2008. 12(18): F.241–7.

Watts D.H., Balasubramanian R., Maupin R.T., et al. Maternal toxicity and pregnancy complications in human immunodeficiency virus-infected women receiving antiretroviral therapy: PACTG 316 // Am J Obstet Gynecol 2004; 190.

de Andrade, C.M. Duarte, G. Quintana, S.M. Montes, M.B.A. Toloi, M.R.T. Effect of antiretroviral therapy on hemostasis in Brazilian pregnant women with HIV infection // J. Blood Coagulation and fibrinolysis. 2007, Vol. 18; NUMB 8, P. 769–774.

Fabricius EM, Schramm W, Goebel FD, Schmitz K, Patzak A, Hammel G // International Conference on AIDS. Fibrinolysis and endothelin in retinal and conjunctival microangiopathy in HIV-infection // IntConf AIDS. 2002 Jul. 19–24; 8: 77 (abstract no. PuB 7172).

Richard O., Judith E.А., HelenOgefere O., Evelyn Omokaro U., and Chinedu C. Haemorheologic and fibrinolytic activity in Nigerian HIV infected patients // Health Sci. 2008 December; 8(4): 217–219.

Swindells, S., Zheng, J. &Gendelman, H. E. (2006) HIV-associated dementia: new insights into disease pathogenesis and therapeutic interventions // AID S Patient Care and STDs, 13, P. 153–163.

Crane H. M., Van Rompaey S. E., Kitahata M. M. Antiretroviral medications associated with elevated blood pressure among patients receiving highly active antiretroviral therapy // AIDS. 2006; 20 (7): 1019–1026.

Evron S., Glezerman M., Harow E. et al. Human immunodeficiency virus: anesthetic and obstetric considerations // Anesth. Analg. 2004; 98 (2): 503—511.

Turjanski N., Lloyd G. G. Psychiatric side-effects of medications: recent developments // Adv. Psychiatr. Treat. 2005; 11: 58–70.

Hignett R., Fernando R. Anesthesia for the pregnant HIV patient // Anesthesiol. Clin. 2008; 26 (1): 127–143.

Treisman G. J., Kaplin Al. Neurologic and psychiatric complications of antiretroviral agents // AIDS. 2002; 16 (9): 1201–1215.

Avidan M. S., Groves P., Blott M. et al. Low complication rate associated with cesarean section under spinal anesthesia for HIV-1-infected women on antiretroviral therapy // Anesthesiology. 2002; 97 (2): 320–324.

Bremerich D. H., Ahr A., Buchner S. et al. Anesthetic regimen for HIV positive parturients undergoing elective cesarean section // Anaesthesist 2003; 52 (12): 1124–1131.

Kuczkowski K. M. Anesthetic considerations for the HIV-infected pregnant patient // Yonsei Med. J. 2004; 45 (1): 1–6.

How to Cite
Grigimalsky EV, Garga AI, Tarasov AV, Dovgiy IN, Budnyk NN. An anesthesiologist’s view of problems in HIV-positive patients. prmd [Internet]. 16May2018 [cited 22Apr.2019];1(1):66-9. Available from:
Clinical thinking